Literature DB >> 23482350

Coronary artery abnormalities in Kawasaki disease: comparison between CT and MR coronary angiography.

Jong Woo Kim1, Hyun Woo Goo.   

Abstract

BACKGROUND: Although CT coronary angiography (CTCA) and MR coronary angiography (MRCA) are increasingly used in patients with Kawasaki disease, comparison of coronary artery assessibility and diagnostic performance between the two imaging modalities has been rarely performed.
PURPOSE: To investigate which imaging modality, CTCA or MRCA, is better for evaluating coronary artery abnormalities in patients with Kawasaki disease.
MATERIAL AND METHODS: Between 2003 and 2011, 56 patients (38 boys/men; age range, 1-24 years) with Kawasaki disease underwent CTCA or MRCA (group A). Of these, 17 underwent both CTCA and MRCA (group B). Visibility of 11 coronary arterial segments in each patient was graded on a four-point scale. Coronary artery aneurysm, stenosis, and occlusion were evaluated by CTCA and MRCA, based on a reference standard obtained from cardiac catheterization, echocardiography, follow-up CTCA and MRCA, and clinical history. Coronary artery assessibility and diagnostic performance were compared between CTCA and MRCA.
RESULTS: In per-segment analysis, more segments were assessable on CTCA than on MRCA in both groups. In per-patient analysis of group B, no significant difference in the assessibility was found between CTCA (95.0%, 128.3/135 segments) and MRCA (92.4%, 124.8/135 segments) (P > 0.05). Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of CTCA vs. MRCA were 93.1% vs. 77.9% (P < 0.001), 99.2% vs. 99.7% (P = 0.65), 96.8% vs. 98.7% (P = 0.65), 98.2% vs. 94.1% (P < 0.001), and 98.0% vs. 94.9% (P = 0.008), respectively, in group A, and 91.8% vs. 70.4% (P < 0.001), 99.5% vs. 99.5% (P = 1.000), 98.5% vs. 98.0% (P = 1.000), 97.2% vs. 91.1% (P = 0.006), and 97.6% vs. 92.3% (P = 0.004), respectively, in group B.
CONCLUSION: Although CTCA and MRCA show comparable assessibility in per-patient analysis, CTCA shows higher diagnostic performance than MRCA for evaluating coronary artery abnormalities in patients with Kawasaki disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23482350     DOI: 10.1258/ar.2012.120484

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  16 in total

1.  Third-generation dual-source 70-kVp chest CT angiography with advanced iterative reconstruction in young children: image quality and radiation dose reduction.

Authors:  Oliver Rompel; Martin Glöckler; Rolf Janka; Sven Dittrich; Robert Cesnjevar; Michael M Lell; Michael Uder; Matthias Hammon
Journal:  Pediatr Radiol       Date:  2016-01-06

2.  Quantitative evaluation of coronary artery visibility on CT angiography in Kawasaki disease: young vs. old children.

Authors:  Hyun Woo Goo
Journal:  Int J Cardiovasc Imaging       Date:  2020-10-12       Impact factor: 2.357

3.  Identification of coronary artery anatomy on dual-source cardiac computed tomography before arterial switch operation in newborns and young infants: comparison with transthoracic echocardiography.

Authors:  Hyun Woo Goo
Journal:  Pediatr Radiol       Date:  2017-10-14

Review 4.  Radiation dose management for pediatric cardiac computed tomography: a report from the Image Gently 'Have-A-Heart' campaign.

Authors:  Cynthia K Rigsby; Sarah E McKenney; Kevin D Hill; Anjali Chelliah; Andrew J Einstein; B Kelly Han; Joshua D Robinson; Christina L Sammet; Timothy C Slesnick; Donald P Frush
Journal:  Pediatr Radiol       Date:  2018-01-01

5.  ECG-synchronized CT angiography in 324 consecutive pediatric patients: spectrum of indications and trends in radiation dose.

Authors:  Felix G Meinel; Thomas Henzler; U Joseph Schoepf; Patsy W Park; Walter Huda; James V Spearman; Kevin T Dyer; Anil G Rao; Anthony M Hlavacek
Journal:  Pediatr Cardiol       Date:  2014-11-08       Impact factor: 1.655

Review 6.  Imaging Evaluation of Kawasaki Disease.

Authors:  Pei-Ni Jone; Jennifer Romanowicz; Lorna Browne; LaDonna J Malone
Journal:  Curr Cardiol Rep       Date:  2022-08-20       Impact factor: 3.955

Review 7.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the Use of Cardiac Magnetic Resonance in Pediatric Congenital and Acquired Heart Disease: Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  Circ Cardiovasc Imaging       Date:  2022-06-21       Impact factor: 8.589

Review 8.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the use of cardiovascular magnetic resonance in pediatric congenital and acquired heart disease : Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  J Cardiovasc Magn Reson       Date:  2022-06-21       Impact factor: 6.903

Review 9.  Sudden cardiac death from structural heart diseases in adults: imaging findings with cardiovascular computed tomography and magnetic resonance.

Authors:  Song Soo Kim; Sung Min Ko; Sang Il Choi; Bo Hwa Choi; Arthur E Stillman
Journal:  Int J Cardiovasc Imaging       Date:  2016-05-02       Impact factor: 2.357

Review 10.  The emerging role of cardiovascular magnetic resonance in the evaluation of Kawasaki disease.

Authors:  Sophie Mavrogeni; George Papadopoulos; Tarique Hussain; Amedeo Chiribiri; Rene Botnar; Gerald F Greil
Journal:  Int J Cardiovasc Imaging       Date:  2013-08-15       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.